Data presented at AD/PD show that targeting miR-27b may influence several interconnected biological processes implicated in Parkinson's disease.

Find out where you can connect with our team this year

At the American Epilepsy Society Annual Meeting, Neumirna presented two posters highlighting the potential of its RNA-based approach for drug-resistant epilepsy.